Cystourethroscopes

Welcome to Cystourethroscopes Site
Cystourethroscopes Resources

Home > Cystourethroscopes > Altus Pharmaceuticals Announces Presentation Of Phase 3 Trizytek Efficacy Data At The North American Cystic Fibrosis Conference

Altus Pharmaceuticals Announces Presentation Of Phase 3 Trizytek Efficacy Data At The North American Cystic Fibrosis Conference




Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced that the Trizytek TM (liprotamase) Phase 3 efficacy study results will be presented at oral and poster sessions at the 2008 North American Cystic Fibrosis Conference (NACFC) in Orlando, FL on October 23 and 24. Trizytek is a non-porcine derived enzyme replacement therapy for patients with pancreatic insufficiency. The Phase 3 Trizytek efficacy results will be presented by Dr.


Click Here to read the entire article...




Other Articles:


Listen to The Lancet: 11 October
Listen to Vikram Patel in this week's podcast and visit the website of the Movement for Global Mental Health for further information.
Click Here to read the entire article...
Fireworks
none
Click Here to read the entire article...
ZOOM RHYTHMTRAK RT-323 DRUM MACHINE
£20.00 (0 Bid)
End Date: Monday Dec-01-2008 22:08:30 GMT
Bid now | Add to watch list
Click Here to read the entire article...
Medtech Startups, December 2007
New medical technologies represented in companies added (December 2007) to the Medtech Startups Database and/or added to the December 2007 issue of MedMarkets.

The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of December:

  • EEG analysis for applications such as detection and prediction of seizure.
  • Drugs targeting inflammatory and metabolic pathways, including obesity, type 2 diabetes and cardiovascular disease.
  • In vivo transdifferentiation to regenerate ischemic or diseased organs.
  • Developing small molecule drugs to reprogram adult stem cells.
  • Orthopedic devices for pediatric and other small stature patients.
  • Devices and apparatus for insertion of flexible implants (e.g. breast implants, others).
  • Implantable devices; e.g., to prevent cerebrospinal fluid leaks.
  • Minimally invasive spinal instrumentation.
  • Intra-operative 3D imaging for earlier diagnosis of breast cancer.

Now Published!: Worldwide Wound Management 2007-2016. see link

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Tags: medtech, startup
Click Here to read the entire article...
Teething syrup suspected of killing 24 Nigerian kids (Reuters)
Reuters - Two dozen children have died and nine have fallen ill in Nigeria during the last three weeks after being given teething syrup, the health minister said on Tuesday.
Click Here to read the entire article...
[Medical_Sciences] Inaugural Article: Digoxin and other cardiac glycosides inhibit HIF-1{alpha} synthesis and block tumor growth

A library of drugs that are in clinical trials or use was screened for inhibitors of hypoxia-inducible factor 1 (HIF-1)....

Click Here to read the entire article...
Cystic Fibrosis News From Medical News Today
By editors@medicalnewstoday.com (MNT Editors) - Copyright 2008 Medical News Today - version: v1.5 build A